Carotid endarterectomy surgery
This article was originally published in The Gray Sheet
Executive Summary
Preliminary feedback from a trial of EndoTex's NextStent carotid stent with Boston Scientific's FilterWire EX embolic protection device is "promising," according to Boston Scientific Peripheral Interventions Business President Matthew Jenusaitis. CABERNET recently completed enrollment of 450 patients ineligible for carotid endarterectomy surgery at 15 U.S. centers, the firms announced March 25. Boston Scientific will be the exclusive distributor for NextStent and has the option to buy EndoTex under the terms of a May 2003 agreement extension (1"The Gray Sheet" May 26, 2003, p. 26)...